Billingham LJ[au] - Search Results

Year	Number of Results
1996	3
1997	2
1999	5
2001	1
2002	3
2003	1
2005	1
2006	3
2007	5
2008	3
2009	3
2010	1
2011	5
2012	2
2013	1
2014	1
2015	2
2016	3
2017	3
2018	1
2019	3
2022	0

1

Clinical trial design in hepatocellular carcinoma.

Johnson PJ, Billingham LJ. Johnson PJ, et al. Among authors: billingham lj. Best Pract Res Clin Gastroenterol. 2005 Feb;19(1):119-27. doi: 10.1016/j.bpg.2004.11.004. Best Pract Res Clin Gastroenterol. 2005. PMID: 15757808 Review.

2

Guidelines for preclinical and early phase clinical assessment of novel radiosensitisers.

Harrington KJ, Billingham LJ, Brunner TB, Burnet NG, Chan CS, Hoskin P, Mackay RI, Maughan TS, Macdougall J, McKenna WG, Nutting CM, Oliver A, Plummer R, Stratford IJ, Illidge T. Harrington KJ, et al. Among authors: billingham lj. Br J Cancer. 2011 Aug 23;105(5):628-39. doi: 10.1038/bjc.2011.240. Epub 2011 Jul 19. Br J Cancer. 2011. PMID: 21772330 Free PMC article. Review. No abstract available.

3

Patients choose certainty over burden in bladder cancer surveillance.

van Osch FHM, Nekeman D, Aaronson NK, Billingham LJ, James ND, Cheng KK, Bryan RT, Zeegers MP. van Osch FHM, et al. Among authors: billingham lj. World J Urol. 2019 Dec;37(12):2747-2753. doi: 10.1007/s00345-019-02728-4. Epub 2019 Mar 23. World J Urol. 2019. PMID: 30903352 Free PMC article.

4

Radiotherapy research priorities for the UK.

Maughan TS, Illidge TM, Hoskin P, McKenna WG, Brunner TB, Stratford IJ, Harrington KJ, Plummer R, Billingham LJ, Nutting C, Burnet NG, Mackay RI, Oliver A, Young C, Chan CS; NCRI Clinical and Translational Radiotherapy Research Working Group. Maughan TS, et al. Among authors: billingham lj. Clin Oncol (R Coll Radiol). 2010 Oct;22(8):707-9. doi: 10.1016/j.clon.2010.03.006. Epub 2010 Apr 2. Clin Oncol (R Coll Radiol). 2010. PMID: 20363111 No abstract available.

5

Palliative chemotherapy: no longer a contradiction in terms.

Archer VR, Billingham LJ, Cullen MH. Archer VR, et al. Among authors: billingham lj. Oncologist. 1999;4(6):470-7. Oncologist. 1999. PMID: 10631691 Free article. Review.

6

Simultaneous analysis of quality of life and survival data.

Billingham LJ, Abrams KR. Billingham LJ, et al. Stat Methods Med Res. 2002 Feb;11(1):25-48. doi: 10.1191/0962280202sm269ra. Stat Methods Med Res. 2002. PMID: 11923992 Review.

7

Methods for the analysis of quality-of-life and survival data in health technology assessment.

Billingham LJ, Abrams KR, Jones DR. Billingham LJ, et al. Health Technol Assess. 1999;3(10):1-152. Health Technol Assess. 1999. PMID: 10627631 Free article. Review. No abstract available.

8

Health-related quality of life around the time of diagnosis in patients with bladder cancer.

Yu EY, Nekeman D, Billingham LJ, James ND, Cheng KK, Bryan RT, Wesselius A, Zeegers MP. Yu EY, et al. Among authors: billingham lj. BJU Int. 2019 Dec;124(6):984-991. doi: 10.1111/bju.14804. Epub 2019 Jun 7. BJU Int. 2019. PMID: 31077532 Free PMC article.

9

Methodological considerations in the evaluation of radiotherapy technologies.

Burnet NG, Billingham LJ, Chan CS, Hall E, Macdougall J, Mackay RI, Maughan TS, Nutting CM, Staffurth JN, Illidge TM; National Cancer Research Institute Clinical and Translational Radiotherapy Research Working Group Executive Group. Burnet NG, et al. Among authors: billingham lj. Clin Oncol (R Coll Radiol). 2012 Dec;24(10):707-9. doi: 10.1016/j.clon.2012.06.003. Epub 2012 Jul 12. Clin Oncol (R Coll Radiol). 2012. PMID: 22795231 No abstract available.

10

Can we afford to ignore missing data in cost-effectiveness analyses?

Marshall A, Billingham LJ, Bryan S. Marshall A, et al. Among authors: billingham lj. Eur J Health Econ. 2009 Feb;10(1):1-3. doi: 10.1007/s10198-008-0129-y. Eur J Health Econ. 2009. PMID: 18936993 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results